Report Detail

Pharma & Healthcare Global Anti-Inflammatory Cytokine Market Research Report 2022

  • RnM4438738
  • |
  • 11 May, 2022
  • |
  • Global
  • |
  • 92 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Anti-Inflammatory Cytokine Market Overview

    • 1.1 Product Overview and Scope of Anti-Inflammatory Cytokine
    • 1.2 Anti-Inflammatory Cytokine Segment by Type
      • 1.2.1 Global Anti-Inflammatory Cytokine Sales Growth Rate Comparison by Type (2022-2028)
      • 1.2.2 Oral
      • 1.2.3 Intravenous
      • 1.2.4 Others
    • 1.3 Anti-Inflammatory Cytokine Segment by Application
      • 1.3.1 Global Anti-Inflammatory Cytokine Sales Comparison by Application: (2022-2028)
      • 1.3.2 Cardiovascular Diseases
      • 1.3.3 Osteoarthritis
      • 1.3.4 Others
    • 1.4 Global Anti-Inflammatory Cytokine Market Size Estimates and Forecasts
      • 1.4.1 Global Anti-Inflammatory Cytokine Revenue 2017-2028
      • 1.4.2 Global Anti-Inflammatory Cytokine Sales 2017-2028
      • 1.4.3 Anti-Inflammatory Cytokine Market Size by Region: 2017 Versus 2021 Versus 2028

    2 Anti-Inflammatory Cytokine Market Competition by Manufacturers

    • 2.1 Global Anti-Inflammatory Cytokine Sales Market Share by Manufacturers (2017-2022)
    • 2.2 Global Anti-Inflammatory Cytokine Revenue Market Share by Manufacturers (2017-2022)
    • 2.3 Global Anti-Inflammatory Cytokine Average Price by Manufacturers (2017-2022)
    • 2.4 Manufacturers Anti-Inflammatory Cytokine Manufacturing Sites, Area Served, Product Type
    • 2.5 Anti-Inflammatory Cytokine Market Competitive Situation and Trends
      • 2.5.1 Anti-Inflammatory Cytokine Market Concentration Rate
      • 2.5.2 The Global Top 5 and Top 10 Largest Anti-Inflammatory Cytokine Players Market Share by Revenue
      • 2.5.3 Global Anti-Inflammatory Cytokine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

    3 Anti-Inflammatory Cytokine Retrospective Market Scenario by Region

    • 3.1 Global Anti-Inflammatory Cytokine Retrospective Market Scenario in Sales by Region: 2017-2022
    • 3.2 Global Anti-Inflammatory Cytokine Retrospective Market Scenario in Revenue by Region: 2017-2022
    • 3.3 North America Anti-Inflammatory Cytokine Market Facts & Figures by Country
      • 3.3.1 North America Anti-Inflammatory Cytokine Sales by Country
      • 3.3.2 North America Anti-Inflammatory Cytokine Revenue by Country
      • 3.3.3 United States
      • 3.3.4 Canada
    • 3.4 Europe Anti-Inflammatory Cytokine Market Facts & Figures by Country
      • 3.4.1 Europe Anti-Inflammatory Cytokine Sales by Country
      • 3.4.2 Europe Anti-Inflammatory Cytokine Revenue by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Anti-Inflammatory Cytokine Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Anti-Inflammatory Cytokine Sales by Region
      • 3.5.2 Asia Pacific Anti-Inflammatory Cytokine Revenue by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 China Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
    • 3.6 Latin America Anti-Inflammatory Cytokine Market Facts & Figures by Country
      • 3.6.1 Latin America Anti-Inflammatory Cytokine Sales by Country
      • 3.6.2 Latin America Anti-Inflammatory Cytokine Revenue by Country
      • 3.6.3 Mexico
      • 3.6.4 Brazil
      • 3.6.5 Argentina
    • 3.7 Middle East and Africa Anti-Inflammatory Cytokine Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Anti-Inflammatory Cytokine Sales by Country
      • 3.7.2 Middle East and Africa Anti-Inflammatory Cytokine Revenue by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 UAE

    4 Global Anti-Inflammatory Cytokine Historic Market Analysis by Type

    • 4.1 Global Anti-Inflammatory Cytokine Sales Market Share by Type (2017-2022)
    • 4.2 Global Anti-Inflammatory Cytokine Revenue Market Share by Type (2017-2022)
    • 4.3 Global Anti-Inflammatory Cytokine Price by Type (2017-2022)

    5 Global Anti-Inflammatory Cytokine Historic Market Analysis by Application

    • 5.1 Global Anti-Inflammatory Cytokine Sales Market Share by Application (2017-2022)
    • 5.2 Global Anti-Inflammatory Cytokine Revenue Market Share by Application (2017-2022)
    • 5.3 Global Anti-Inflammatory Cytokine Price by Application (2017-2022)

    6 Key Companies Profiled

    • 6.1 Merck KGaA
      • 6.1.1 Merck KGaA Corporation Information
      • 6.1.2 Merck KGaA Description and Business Overview
      • 6.1.3 Merck KGaA Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.1.4 Merck KGaA Anti-Inflammatory Cytokine Product Portfolio
      • 6.1.5 Merck KGaA Recent Developments/Updates
    • 6.2 Eli Lilly and Company
      • 6.2.1 Eli Lilly and Company Corporation Information
      • 6.2.2 Eli Lilly and Company Description and Business Overview
      • 6.2.3 Eli Lilly and Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.2.4 Eli Lilly and Company Anti-Inflammatory Cytokine Product Portfolio
      • 6.2.5 Eli Lilly and Company Recent Developments/Updates
    • 6.3 Pfizer Inc.
      • 6.3.1 Pfizer Inc. Corporation Information
      • 6.3.2 Pfizer Inc. Description and Business Overview
      • 6.3.3 Pfizer Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.3.4 Pfizer Inc. Anti-Inflammatory Cytokine Product Portfolio
      • 6.3.5 Pfizer Inc. Recent Developments/Updates
    • 6.4 Sanofi S.A.
      • 6.4.1 Sanofi S.A. Corporation Information
      • 6.4.2 Sanofi S.A. Description and Business Overview
      • 6.4.3 Sanofi S.A. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Sanofi S.A. Anti-Inflammatory Cytokine Product Portfolio
      • 6.4.5 Sanofi S.A. Recent Developments/Updates
    • 6.5 Novartis AG
      • 6.5.1 Novartis AG Corporation Information
      • 6.5.2 Novartis AG Description and Business Overview
      • 6.5.3 Novartis AG Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.5.4 Novartis AG Anti-Inflammatory Cytokine Product Portfolio
      • 6.5.5 Novartis AG Recent Developments/Updates
    • 6.6 Hoffmann-La Roche Ltd.
      • 6.6.1 Hoffmann-La Roche Ltd. Corporation Information
      • 6.6.2 Hoffmann-La Roche Ltd. Description and Business Overview
      • 6.6.3 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.6.4 Hoffmann-La Roche Ltd. Anti-Inflammatory Cytokine Product Portfolio
      • 6.6.5 Hoffmann-La Roche Ltd. Recent Developments/Updates
    • 6.7 Lonza Group Ltd.
      • 6.6.1 Lonza Group Ltd. Corporation Information
      • 6.6.2 Lonza Group Ltd. Description and Business Overview
      • 6.6.3 Lonza Group Ltd. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.4.4 Lonza Group Ltd. Anti-Inflammatory Cytokine Product Portfolio
      • 6.7.5 Lonza Group Ltd. Recent Developments/Updates
    • 6.8 Thermo Fisher Scientific
      • 6.8.1 Thermo Fisher Scientific Corporation Information
      • 6.8.2 Thermo Fisher Scientific Description and Business Overview
      • 6.8.3 Thermo Fisher Scientific Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.8.4 Thermo Fisher Scientific Anti-Inflammatory Cytokine Product Portfolio
      • 6.8.5 Thermo Fisher Scientific Recent Developments/Updates
    • 6.9 Meridian Bioscience Inc.
      • 6.9.1 Meridian Bioscience Inc. Corporation Information
      • 6.9.2 Meridian Bioscience Inc. Description and Business Overview
      • 6.9.3 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.9.4 Meridian Bioscience Inc. Anti-Inflammatory Cytokine Product Portfolio
      • 6.9.5 Meridian Bioscience Inc. Recent Developments/Updates
    • 6.10 General Electric Company
      • 6.10.1 General Electric Company Corporation Information
      • 6.10.2 General Electric Company Description and Business Overview
      • 6.10.3 General Electric Company Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.10.4 General Electric Company Anti-Inflammatory Cytokine Product Portfolio
      • 6.10.5 General Electric Company Recent Developments/Updates
    • 6.11 Abcam PLC
      • 6.11.1 Abcam PLC Corporation Information
      • 6.11.2 Abcam PLC Anti-Inflammatory Cytokine Description and Business Overview
      • 6.11.3 Abcam PLC Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.11.4 Abcam PLC Anti-Inflammatory Cytokine Product Portfolio
      • 6.11.5 Abcam PLC Recent Developments/Updates
    • 6.12 GenScript Biotech Corp
      • 6.12.1 GenScript Biotech Corp Corporation Information
      • 6.12.2 GenScript Biotech Corp Anti-Inflammatory Cytokine Description and Business Overview
      • 6.12.3 GenScript Biotech Corp Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.12.4 GenScript Biotech Corp Anti-Inflammatory Cytokine Product Portfolio
      • 6.12.5 GenScript Biotech Corp Recent Developments/Updates
    • 6.13 Applied Biological Materials Inc.
      • 6.13.1 Applied Biological Materials Inc. Corporation Information
      • 6.13.2 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Description and Business Overview
      • 6.13.3 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.13.4 Applied Biological Materials Inc. Anti-Inflammatory Cytokine Product Portfolio
      • 6.13.5 Applied Biological Materials Inc. Recent Developments/Updates
    • 6.14 Randox Laboratories
      • 6.14.1 Randox Laboratories Corporation Information
      • 6.14.2 Randox Laboratories Anti-Inflammatory Cytokine Description and Business Overview
      • 6.14.3 Randox Laboratories Anti-Inflammatory Cytokine Sales, Revenue and Gross Margin (2017-2022)
      • 6.14.4 Randox Laboratories Anti-Inflammatory Cytokine Product Portfolio
      • 6.14.5 Randox Laboratories Recent Developments/Updates

    7 Anti-Inflammatory Cytokine Manufacturing Cost Analysis

    • 7.1 Anti-Inflammatory Cytokine Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Anti-Inflammatory Cytokine
    • 7.4 Anti-Inflammatory Cytokine Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Anti-Inflammatory Cytokine Distributors List
    • 8.3 Anti-Inflammatory Cytokine Customers

    9 Anti-Inflammatory Cytokine Market Dynamics

    • 9.1 Anti-Inflammatory Cytokine Industry Trends
    • 9.2 Anti-Inflammatory Cytokine Market Drivers
    • 9.3 Anti-Inflammatory Cytokine Market Challenges
    • 9.4 Anti-Inflammatory Cytokine Market Restraints

    10 Global Market Forecast

    • 10.1 Anti-Inflammatory Cytokine Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Anti-Inflammatory Cytokine by Type (2023-2028)
      • 10.1.2 Global Forecasted Revenue of Anti-Inflammatory Cytokine by Type (2023-2028)
    • 10.2 Anti-Inflammatory Cytokine Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Anti-Inflammatory Cytokine by Application (2023-2028)
      • 10.2.2 Global Forecasted Revenue of Anti-Inflammatory Cytokine by Application (2023-2028)
    • 10.3 Anti-Inflammatory Cytokine Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Anti-Inflammatory Cytokine by Region (2023-2028)
      • 10.3.2 Global Forecasted Revenue of Anti-Inflammatory Cytokine by Region (2023-2028)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      Summary:

      Anti-Inflammatory Cytokine is categorised as a large group of peptides, glycoproteins and proteins that are present into specific cells in the immune system. Cytokines are produced in the body may have different origins like lymphocytes, monocytes and others. Anti-inflammatory cytokines are regulatory molecule for a pro-inflammation response from cytokines. Inflammatory cytokines can lead to cytokine storm causing nerve-injury/inflammation-induced central sensitization, atherosclerosis or cancer.
      Industry Insights
      Due to the COVID-19 pandemic, the global Anti-Inflammatory Cytokine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Anti-Inflammatory Cytokine market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Anti-Inflammatory Cytokine landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
      Oral accounting for % of the Anti-Inflammatory Cytokine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Cardiovascular Diseases segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
      The global major manufacturers of Anti-Inflammatory Cytokine include Merck KGaA, Eli Lilly and Company, Pfizer Inc., Sanofi S.A., Novartis AG, Hoffmann-La Roche Ltd., Lonza Group Ltd., Thermo Fisher Scientific and Meridian Bioscience Inc., etc. In terms of revenue, the global 3 largest players have a % market share of Anti-Inflammatory Cytokine in 2021.
      This report focuses on Anti-Inflammatory Cytokine volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Anti-Inflammatory Cytokine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
      Key Drivers & Barriers
      High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
      Post-covid-19 Outlook
      The readers in the section will understand how the Anti-Inflammatory Cytokine market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
      Segmental Outlook
      Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).
      Segment by Type
      Oral
      Intravenous
      Others
      Segment by Application
      Cardiovascular Diseases
      Osteoarthritis
      Others
      Regional Outlook
      This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Scenario
      In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
      Merck KGaA
      Eli Lilly and Company
      Pfizer Inc.
      Sanofi S.A.
      Novartis AG
      Hoffmann-La Roche Ltd.
      Lonza Group Ltd.
      Thermo Fisher Scientific
      Meridian Bioscience Inc.
      General Electric Company
      Abcam PLC
      GenScript Biotech Corp
      Applied Biological Materials Inc.
      Randox Laboratories
      Frequently Asked Questions
      Which product segment grabbed the largest share in the Anti-Inflammatory Cytokine market?
      How is the competitive scenario of the Anti-Inflammatory Cytokine market?
      Which are the key factors aiding the Anti-Inflammatory Cytokine market growth?
      Which are the prominent players in the Anti-Inflammatory Cytokine market?
      Which region holds the maximum share in the Anti-Inflammatory Cytokine market?
      What will be the CAGR of the Anti-Inflammatory Cytokine market during the forecast period?
      Which application segment emerged as the leading segment in the Anti-Inflammatory Cytokine market?
      What key trends are likely to emerge in the Anti-Inflammatory Cytokine market in the coming years?
      What will be the Anti-Inflammatory Cytokine market size by 2028?
      Which company held the largest share in the Anti-Inflammatory Cytokine market?


      Summary:
      Get latest Market Research Reports on Anti-Inflammatory Cytokine. Industry analysis & Market Report on Anti-Inflammatory Cytokine is a syndicated market report, published as Global Anti-Inflammatory Cytokine Market Research Report 2022. It is complete Research Study and Industry Analysis of Anti-Inflammatory Cytokine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,900.00
      $5,800.00
      2,322.90
      4,645.80
      2,746.30
      5,492.60
      371,461.00
      742,922.00
      225,881.00
      451,762.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report